---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-097018"
form_type: "8-K"
ticker: "GRML"
cik: "0001907223"
company_name: "Greenland Mines Ltd"
filed_at: "2024-11-13T23:59:59+00:00"
generated_at: "2026-05-30T01:13:23.987871+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Klotho terminates licensing deal for gamma-melanocortin MC1R rights

## Summary
- Mutual termination of Jan 28, 2023 licensing agreement with Teleost Biopharmaceuticals.
- Licensed rights no longer core to Klotho's business and research plans.
- No further obligations or liabilities between parties; confidentiality survives.
- Agreement covered worldwide rights to develop gamma-melanocortin drugs targeting MC1R receptors.

## SEC filing metadata
- accession: 0001213900-24-097018
- form_type: 8-K
- ticker: GRML
- cik: 0001907223
- company_name: Greenland Mines Ltd
- filed_at: 2024-11-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1907223/000121390024097018/0001213900-24-097018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1907223/000121390024097018/ea0220976-8k_klotho.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-097018
- JSON: https://secwatch.observer/filing/0001213900-24-097018.json
- Plain text: https://secwatch.observer/filing/0001213900-24-097018.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.